XTX Topco Ltd Buys Shares of 3,555 Maximus, Inc. (NYSE:MMS)

XTX Topco Ltd bought a new stake in Maximus, Inc. (NYSE:MMSFree Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,555 shares of the health services provider’s stock, valued at approximately $305,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Rise Advisors LLC grew its stake in Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 289 shares during the period. GAMMA Investing LLC grew its stake in Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 238 shares during the period. Blue Trust Inc. grew its stake in Maximus by 201.5% in the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 262 shares during the period. Kapitalo Investimentos Ltda acquired a new position in Maximus in the fourth quarter valued at about $52,000. Finally, Archer Investment Corp grew its stake in Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after acquiring an additional 791 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Up 0.9 %

NYSE:MMS opened at $92.70 on Friday. The stock has a market cap of $5.64 billion, a price-to-earnings ratio of 24.33 and a beta of 0.76. The stock has a 50-day moving average price of $89.92 and a two-hundred day moving average price of $86.37. Maximus, Inc. has a 1 year low of $72.39 and a 1 year high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.78 earnings per share. As a group, equities analysts expect that Maximus, Inc. will post 6.12 earnings per share for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Stockholders of record on Thursday, August 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.29%. Maximus’s dividend payout ratio (DPR) is 31.50%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.